DK0868526T3 - Fremgangsmåde til fremstilling af N-acetyl(L)-4-cyanophenylalanin Ac-(L)-Phe(4-CN)-OH og N-acetyl-(L)-p-amidinophenylalanincyclohexylglycin-beta-(3-N-methylpyridinium)-alanin Ac-(L)-pAph-Chg-PalMe(3)-NH2 - Google Patents

Fremgangsmåde til fremstilling af N-acetyl(L)-4-cyanophenylalanin Ac-(L)-Phe(4-CN)-OH og N-acetyl-(L)-p-amidinophenylalanincyclohexylglycin-beta-(3-N-methylpyridinium)-alanin Ac-(L)-pAph-Chg-PalMe(3)-NH2

Info

Publication number
DK0868526T3
DK0868526T3 DK96942085T DK96942085T DK0868526T3 DK 0868526 T3 DK0868526 T3 DK 0868526T3 DK 96942085 T DK96942085 T DK 96942085T DK 96942085 T DK96942085 T DK 96942085T DK 0868526 T3 DK0868526 T3 DK 0868526T3
Authority
DK
Denmark
Prior art keywords
acetyl
paph
amidinophenylalanine
palme
cyanophenylalanine
Prior art date
Application number
DK96942085T
Other languages
Danish (da)
English (en)
Inventor
Chi-Hsin R King
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK0868526T3 publication Critical patent/DK0868526T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cosmetics (AREA)
DK96942085T 1995-12-20 1996-11-25 Fremgangsmåde til fremstilling af N-acetyl(L)-4-cyanophenylalanin Ac-(L)-Phe(4-CN)-OH og N-acetyl-(L)-p-amidinophenylalanincyclohexylglycin-beta-(3-N-methylpyridinium)-alanin Ac-(L)-pAph-Chg-PalMe(3)-NH2 DK0868526T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57556995A 1995-12-20 1995-12-20
PCT/US1996/019005 WO1997022712A1 (en) 1995-12-20 1996-11-25 NOVEL PROCESS FOR PREPARING N-ACETYL(L)-4-CYANOPHENYLALANINE Ac-(L)-Phe(4-CN)-OH AND N-ACETYL-(L)-p-AMIDINOPHENYLALANINE-CYCLOHEXYLGLYCINE-β-(3-N-METHYLPYRIDINIUM)-ALANINE Ac-(L)-pAph-Chg-PalMe(3)-NH¿2?

Publications (1)

Publication Number Publication Date
DK0868526T3 true DK0868526T3 (da) 2002-12-02

Family

ID=24300839

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96942085T DK0868526T3 (da) 1995-12-20 1996-11-25 Fremgangsmåde til fremstilling af N-acetyl(L)-4-cyanophenylalanin Ac-(L)-Phe(4-CN)-OH og N-acetyl-(L)-p-amidinophenylalanincyclohexylglycin-beta-(3-N-methylpyridinium)-alanin Ac-(L)-pAph-Chg-PalMe(3)-NH2

Country Status (26)

Country Link
EP (1) EP0868526B1 (de)
JP (1) JP4044614B2 (de)
KR (1) KR100438879B1 (de)
CN (1) CN1087349C (de)
AR (1) AR005119A1 (de)
AT (1) ATE222293T1 (de)
AU (1) AU717995B2 (de)
BR (1) BR9612059A (de)
CA (1) CA2241210C (de)
CZ (1) CZ295362B6 (de)
DE (1) DE69623038T2 (de)
DK (1) DK0868526T3 (de)
EE (1) EE03698B1 (de)
ES (1) ES2179957T3 (de)
IL (1) IL125003A (de)
MX (1) MX9804997A (de)
NO (1) NO319678B1 (de)
NZ (1) NZ324159A (de)
PL (1) PL185541B1 (de)
PT (1) PT868526E (de)
RU (1) RU2170764C2 (de)
SK (1) SK281432B6 (de)
TR (1) TR199801107T2 (de)
UA (1) UA48993C2 (de)
WO (1) WO1997022712A1 (de)
ZA (1) ZA9610600B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010101355A (ko) * 1999-01-02 2001-11-14 로버트 흐라이탁, 미쉘 베스트 신규한 말론산 유도체, 이의 제조 방법, 이의 용도 및이를 함유하는 약제학적 조성물(인자 ｘａ 활성 억제)
EP1016663A1 (de) * 1999-01-02 2000-07-05 Aventis Pharma Deutschland GmbH Neue Malonsäure Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung und pharmazeutische Zusammensetzungen sie enthaltend (Inhibierung der Faktor Xa Aktivität)
PT1254159E (pt) 2000-01-28 2006-07-31 Sanofi Aventis Deutschland Processo para a preparacao de acetil-amidiniofenilalanil-ciclo-hexilglicil-piridilalaninamidas
EP1127884A1 (de) 2000-02-26 2001-08-29 Aventis Pharma Deutschland GmbH Neue Malonsäure Derivaie, Verfahren zu ihrer Herstellung, ihre Verwendung als Inhibitor der Faktor XA Aktivtät und pharmazeutische Zusammensetzungen diese enthaltend
EP1569912B1 (de) 2002-12-03 2015-04-29 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidinderivate als faktor vii-a hemmer
GB0306267D0 (en) * 2003-03-19 2003-04-23 Ineos Fluor Ltd Process
JP2008260755A (ja) * 2007-03-20 2008-10-30 Sumitomo Chemical Co Ltd Ｌ−ビフェニルアラニン化合物の塩の回収方法、およびそれを用いたビフェニルアラニンエステル化合物の回収方法
CN106946724B (zh) * 2017-04-07 2019-03-22 苏州汉德创宏生化科技有限公司 单胺基抑制剂类中间体2-乙酰氨基-2-苄基丙二酸单乙酯的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981799A (en) * 1987-08-21 1991-01-01 Takeda Chemical Industries, Ltd. Acylamino acid racemase, production and use thereof
DE4111394A1 (de) * 1991-04-09 1992-10-15 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
DK0513675T3 (da) * 1991-05-13 1996-09-30 Fujisawa Pharmaceutical Co Hidtil ukendt peptidforbindelse samt fremgangsmåde til fremstilling deraf
HUT76346A (en) * 1994-04-26 1997-08-28 Selectide Corp Factor xa inhibitors

Also Published As

Publication number Publication date
WO1997022712A1 (en) 1997-06-26
AR005119A1 (es) 1999-04-14
JP2000501618A (ja) 2000-02-15
ES2179957T3 (es) 2003-02-01
ATE222293T1 (de) 2002-08-15
JP4044614B2 (ja) 2008-02-06
AU1125197A (en) 1997-07-14
DE69623038T2 (de) 2002-12-12
NO319678B1 (no) 2005-09-05
EP0868526A1 (de) 1998-10-07
AU717995B2 (en) 2000-04-06
CN1205742A (zh) 1999-01-20
TR199801107T2 (xx) 1998-10-21
CA2241210C (en) 2002-05-14
EE03698B1 (et) 2002-04-15
HK1017384A1 (en) 1999-11-19
RU2170764C2 (ru) 2001-07-20
EP0868526B1 (de) 2002-08-14
NZ324159A (en) 1999-07-29
PT868526E (pt) 2002-12-31
PL327314A1 (en) 1998-12-07
SK85598A3 (en) 1998-12-02
MX9804997A (es) 1998-09-30
EE9800188A (et) 1998-12-15
ZA9610600B (en) 1997-06-20
CA2241210A1 (en) 1997-06-26
CZ295362B6 (cs) 2005-07-13
CZ195698A3 (cs) 1999-01-13
IL125003A0 (en) 1999-01-26
NO982868L (no) 1998-08-19
KR20000064486A (ko) 2000-11-06
DE69623038D1 (de) 2002-09-19
BR9612059A (pt) 1999-02-23
CN1087349C (zh) 2002-07-10
IL125003A (en) 2001-12-23
UA48993C2 (uk) 2002-09-16
PL185541B1 (pl) 2003-05-30
KR100438879B1 (ko) 2004-07-16
SK281432B6 (sk) 2001-03-12
NO982868D0 (no) 1998-06-19

Similar Documents

Publication Publication Date Title
DK0833649T3 (da) Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier og fremgangsmåder til fremstilling og anvendelser deraf
ZA964733B (en) Ob protein compositions and methods
NO980255L (no) Antiparasittiske marcfortiner og paraherkvamider
IL117409A0 (en) Flow electroporation chamber and method
NO974494D0 (no) Radiomerkede peptider for diagnostikk og terapi
EP0998324A4 (de) Vaskuläre dichtungsvorrichtung und -verfahren
NO972096D0 (no) Apparat og fremgangsmåte for forlengning og fortykkelse av hår og for festing av hårstykker
ZA969443B (en) Peptides which enhance transport across tissues and methods of identifying and using the same
HUP9801990A3 (en) Peptide and method of obtaining it
GB2299913B (en) Telephony system and method
US5656608B1 (en) Amino acid compositions and methods of treatment using same
DK0839153T3 (da) Fremgangsmåde til fremstilling af peptider og N-carbamoyl-beskyttede peptider
EP0738891A3 (de) Verfahren zum Nachweis von Protein und Kit dafür
NZ319464A (en) Methods and compositions for controlling biofouling using amides
EP0779325A3 (en) Pourous film and preparation process thereof
AU6527496A (en) Anchoring apparatus and method
DK0947079T3 (da) System og fremgangsmåder til internettelefoni
NO990836D0 (no) Antitrombotiske azacykloalkylalkanoylpeptider og pseudopeptider
EE9800188A (et) N-atsetüül-(L)-4-tsüanofenüülalaniini Ac-(L)-Phe- (4-CN)-OH ja N-atsetüül- (L)-p-amidinofenüülalaniintsükloheksüülglütsiin-ß- (3-N-metüülpüridiinium)alaniini Ac-(L)-pAph-Chg-PalMe(3)-NH2 valmistamismeetod
IL116658A0 (en) Peptides their preparation and use
GB9523497D0 (en) Cell membrane protein and application thereof
SI0868526T1 (en) PROCESS FOR PREPARING N-ACETYL(L)-4-CYANOPHENYLALANINE Ac-(L)-Phe(4-CN)-OH AND N-ACETYL-(L)-p-AMIDINOPHENYLALANINE-CYCLOHEXYLGLYCINE-BETA-(3-N-METHYLPYRIDINIUM)-ALANINE Ac-(L)-pAph-Chg-PalMe(3)-NH2
ZA978220B (en) PTX-sensitive G proteins their preparation and use
EP0823056A4 (de) Verfahren zur carboxy-terminalen protein- oder peptidsequenzierung
AU2589497A (en) Constrained cd4 peptides and methods of using the same